Interestingly, we found high expression of antioxidant genes; SOD1, TXN, LAMTOR5, and ATOX1 in prostate cancer patients having higher ERG fusion expression (Figs. 4j and S4k). The gene discussed is TXN; the disease is prostate carcinoma.